Data / Form D filings / CUREMARK LLC
CUREMARK LLC: Form D filings
CUREMARK LLC, a biotechnology company in Rye Brook, NY, filed 14 Form D notices with the SEC between 2009 and 2023. The latest, on March 27, 2023, reports $1.3 million sold of a $15 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 800 WESTCHESTER AVENUE, Rye Brook, NY, 10573
- Phone
- (914) 824-9700
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1439430
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | New notice | $15,000,000 | $1,295,000 | $13,705,000 | 5 | Jan 30, 2023 | sec.gov |
| Apr 14, 2021 | New notice | $5,000,000 | $1,500,000 | $3,500,000 | 2 | Mar 24, 2021 | sec.gov |
| Sep 11, 2019 | New notice | $50,000,000 | $5,405,000 | $44,595,000 | 1 | Aug 29, 2019 | sec.gov |
| Apr 26, 2018 | New notice | $3,000,000 | $1,675,000 | $1,325,000 | 1 | Apr 11, 2018 | sec.gov |
| Jan 29, 2018 | New notice | $80,000,000 | $3,245,000 | $76,755,000 | 1 | Jan 15, 2018 | sec.gov |
| Mar 20, 2017 | New notice | $150,000,000 | $3,000,000 | $147,000,000 | 2 | Mar 6, 2017 | sec.gov |
| Jul 13, 2015 | New notice | $29,525,000 | $20,250,000 | $9,275,000 | 2 | Jun 26, 2015 | sec.gov |
| Jan 14, 2015 | New notice | $17,500,000 | $5,000,000 | $12,500,000 | 1 | Dec 30, 2014 | sec.gov |
| Jan 14, 2014 | New notice | $20,000,000 | $18,752,466 | $1,247,534 | 66 | Jun 28, 2013 | sec.gov |
| Feb 5, 2013 | Amendment | $15,000,000 | $6,042,000 | $8,958,000 | 37 | Feb 28, 2012 | sec.gov |
| Mar 14, 2012 | New notice | $5,000,000 | $2,270,000 | $2,730,000 | 10 | Feb 28, 2012 | sec.gov |
| Jul 29, 2010 | New notice | $10,000,000 | $5,220,000 | $4,780,000 | 3 | Jul 16, 2010 | sec.gov |
| Feb 22, 2010 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
| Jun 19, 2009 | Amendment | $6,500,000 | $6,324,857 | $175,143 | 110 | Nov 21, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kimball Duncan | Director | |
| Joan Fallon | Executive Officer, Director | |
| Leigh Morgan | Director | |
| Afia Asamoah | Director | |
| Matthew Heil | Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Mar 27, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CUREMARK LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.